Gentamicins: A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.
| Trial | Phase | Enrollment | Study Type | Start Date | Status |
|---|
| Randomized Evaluation of a Phytopharmaceutical in Prevention of Severe Oral Mucositis in Patients Receiving Radiotherapy for Oral Cavity, Oropharynx, Hypopharynx, or Cavum Cancer[NCT01066741] | Phase 3 | 78 participants (Actual) | Interventional | 2009-05-31 | Terminated (stopped due to insufficient recruitment, the planed sample size appears not achievable) |
| The Effectiveness of Topical Oral Vitamin D Gel in Prevention of Radiation-induced Oral Mucositis[NCT04308161] | Phase 2 | 45 participants (Anticipated) | Interventional | 2019-11-02 | Recruiting |
| The Effectiveness of Melatonin in Prevention of Radiation-induced Oral Mucositis[NCT03833570] | Phase 2 | 40 participants (Actual) | Interventional | 2018-01-12 | Completed |
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] |
| Article | Year |
|---|
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |
Quality of life, mucositis, and xerostomia from radiotherapy for head and neck cancers: a report from the NCIC CTG HN2 randomized trial of an antimicrobial lozenge to prevent mucositis.Head & neck, 2005, Volume: 27, Issue:5
Topics: Administration, Oral; Anti-Infective Agents; Bacitracin; Carcinoma, Squamous Cell; Clotrimazole; Dou | 2005 |